Epidermal activation of Hedgehog signaling establishes an immunosuppressive microenvironment in basal cell carcinoma by modulating skin immunity.

Grund-Gröschke, S; Ortner, D; Szenes-Nagy, AB; Zaborsky, N; Weiss, R; Neureiter, D; Wipplinger, M; Risch, A; Hammerl, P; Greil, R; Sibilia, M; Gratz, IK; Stoitzner, P; Aberger, F; Mol Oncol. 2020; 14(9):1930-1946

Treatment Landscape for Patients with HER2-Positive Metastatic Breast Cancer: A Review on Emerging Treatment Options.

Gampenrieder, SP; Castagnaviz, V; Rinnerthaler, G; Greil, R CANCER MANAG RES. 2020; 12: 10615-10629.

Impact of PD-L1 Scores and Changes on Clinical Outcome in Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy.

Huemer, F; Klieser, E; Neureiter, D; Schlintl, V; Rinnerthaler, G; Pagès, F; Kirilovsky, A; El Sissy, C; Iglseder, W; Singhartinger, F; Jäger, T; Dinnewitzer, A; Zaborsky, N; Steiner, M; Greil, R; Weiss, L; J Clin Med. 2020; 9(9):

Real-world non-interventional long-term post-authorisation safety study of ruxolitinib in myelofibrosis.

Barraco, F; Greil, R; Herbrecht, R; Schmidt, B; Reiter, A; Willenbacher, W; Raymakers, R; Liersch, R; Wroclawska, M; Pack, R; Burock, K; Karumanchi, D; Gisslinger, H Br J Haematol. 2020; 191(5):764-774

The EndoPredict score predicts response to neoadjuvant chemotherapy and neoendocrine therapy in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer patients from the ABCSG-34 trial.

Dubsky, PC; Singer, CF; Egle, D; Wette, V; Petru, E; Balic, M; Pichler, A; Greil, R; Petzer, AL; Bago-Horvath, Z; Fesl, C; Meek, SM; Kronenwett, R; Rudas, M; Gnant, M; Filipits, M EUR J CANCER. 2020; 134: 99-106.

Combination Strategies for Immune-Checkpoint Blockade and Response Prediction by Artificial Intelligence.

Huemer, F; Leisch, M; Geisberger, R; Melchardt, T; Rinnerthaler, G; Zaborsky, N; Greil, R; Int J Mol Sci. 2020; 21(8):

Interdisciplinary Model for Scheduling Post-discharge Cardiopulmonary Care of Patients Following Severe and Critical SARS-CoV-2 (Coronavirus) Infection.

Kopp, K; Lichtenauer, M; Motloch, LJ; Hoppe, UC; Egle, A; Salzer, HJF; Lamprecht, B; Tomasits, J; Müller, HM; Dieplinger, A; Front Cardiovasc Med. 2020; 7:157

Health-Related Quality of Life in Patients With Hodgkin Lymphoma: A Longitudinal Analysis of the German Hodgkin Study Group.

Kreissl, S; Muller, H; Goergen, H; Meissner, J; Topp, M; Sokler, M; Markova, J; Bernhard, J; Greil, R; von Tresckow, B; Behringer, K; Ruffer, JU; Flechtner, HH; Mostl, M; Fuchs, M; Engert, A; Diehl, V; Borchmann, P J CLIN ONCOL. 2020; 38(25): 2839-2848.

Dabrafenib plus trametinib in patients with BRAF

Subbiah, V; Lassen, U; EElez, E; Italiano, A; Curigliano, G; Javle, M; de Braud, F; Prager, GW; Greil, R; Stein, A; Fasolo, A; Schellens, JHM; Wen, PY; Viele, K; Boran, AD; Gasal, E; Burgess, P; Ilankumaran, P; Wainberg, ZA LANCET ONCOL. 2020; 21(9): 1234-1243.

Prognostic Value of EndoPredict in Women with Hormone Receptor-Positive, HER2-Negative Invasive Lobular Breast Cancer.

Sestak, I; Filipits, M; Buus, R; Rudas, M; Balic, M; Knauer, M; Kronenwett, R; Fitzal, F; Cuzick, J; Gnant, M; Greil, R; Dowsett, M; Dubsky, P CLIN CANCER RES. 2020; 26(17): 4682-4687.